MedTech Navigator Reverse Pitch Series: Stryker

12:30pm Thursday, 12 November 2026
1:30pm Thursday, 12 November 2026
MedTech Livestream

Event Description

Join MedTech Navigator for an exclusive reverse pitch session featuring Stryker, one of the world's leading medical technology companies.

Unlike a traditional pitch event, this session puts the spotlight on Stryker, providing Australian MedTech companies with direct insight into the company's strategic priorities, procurement needs, supply chain challenges, and partnership opportunities. Participants will hear firsthand what Stryker looks for in potential collaborators and gain practical guidance on engaging with a global MedTech leader.

The session will conclude with an interactive Q&A and short company introductions, providing attendees with an opportunity to showcase their capabilities and identify potential areas of alignment.

Attendees will:

  • Gain insight into Stryker's current strategic, procurement and supply chain priorities.
  • Understand the challenges and opportunities where external partners can add value.
  • Learn what global MedTech companies look for in prospective collaborators, suppliers and innovation partners.
  • Better understand expectations around capability, commercial readiness and regulatory requirements.
  • Receive practical guidance on how to effectively approach and engage with multinational MedTech organisations.
  • Build awareness of potential pathways for international partnerships, market access and supply chain integration.

This session is designed for Australian MedTech companies, including:

  • Medical device, diagnostic and digital health (including SaMD) innovators.
  • Early-stage startups, researchers and spinouts progressing towards commercialisation.
  • Growth-stage and established SMEs seeking partnership opportunities with multinational companies.
  • Organisations interested in international market expansion, procurement pathways, strategic partnerships and supply chain integration.
  • Participants in the MedTech Navigator program and the broader Australian MedTech ecosystem.

Recommended for:

Founders, CEOs, business development leaders, commercialisation managers, innovation leads and industry engagement professionals.

Find out more about MedTech Navigator here: https://medtechcompass.org.au/navigator/

MedTech Navigator is delivered in collaboration with the Australian Trade and Investment Commission, Austrade. The Trade Diversification Network has been set up to deliver the Accessing New Markets Initiative, bringing together national peak industry bodies representing Australian exporters.

By combining MTAA’s industry connections with Austrade’s international trade expertise and networks, MedTech Navigator helps Australian companies better understand and prepare for opportunities in global markets.

 

Please note: This webinar will be recorded and may be shared in the future at the discretion of the MTAA and that by registering for this event you agree to MTAA's Terms and Conditions and MTAA's Privacy Policy.

 

Contact Information

Additional Information

Your Speakers

 
James Doyle, Senior Director - Foot & Ankle, Sports Medicine and Trauma. Vice Chair - Board of Directors MTAA

James Doyle leads the Foot & Ankle, Sports Medicine and Trauma divisions for Stryker South Pacific. James has worked with Stryker for 16 years and has been on the Leadership Team in various roles, including Senior Director for Commercial, Public Affairs and Regulatory, supporting non-clinical buyers, government stakeholders and customers in partnership with Stryker’s clinical efforts. He also served as Senior Director, Customer Experience, where he worked in partnership with customers to deliver innovative service and technology solutions, resulting in numerous Australian and international customer service awards. In 2020, in response to the Department of Industry’s COVID-19 response,

James was seconded to the Medical Technology Association of Australia (MTAA) to support the government taskforce securing vital medical supplies, including ventilators, testing kits and PPE for Australia. James led work to secure overseas supplies of ventilators and testing kits. He also oversaw the collaboration of multiple local companies in the production of ventilators and testing swabs in Australia. During this time, James was heavily involved in Stryker’s Australian manufacturing efforts, including the delivery of an Australian-built pandemic response bed. James is a strong advocate for Australian medtech innovation, working closely with local companies to identify partnership opportunities across product distribution and technology development.

In November 2024, James commenced as a Director on the Board of the MTAA, the national association representing the medical technology industry in Australia. He was subsequently elected Vice Chair of the Board and has been reappointed for the 2027-2028 term. The MTAA works with government and stakeholders to ensure access to safe and effective medical technologies, supports industry policy and regulatory reform, and promotes the value of medtech innovation in improving patient outcomes and healthcare delivery. James holds a bachelor’s degree in Sport Science from the University of Teesside, Middlesbrough

 
Teneille Murray, Innovation & Growth Lead, MTAA

As Innovation & Growth Lead at the Medical Technology Association of Australia (MTAA), I work at the intersection of industry, capital and policy to strengthen and scale Australia’s Medtech ecosystem. My focus is on unlocking growth pathways for medical technology companies, from early-stage innovation through to global expansion, and ensuring the right investment, regulatory and commercial settings exist for success. Medtech is not just my sector - it’s my expertise. I bring deep knowledge across innovation pipelines, capital strategy, reimbursement, regulation and commercialisation. I’m passionate about translating complex industry issues into clear, strategic conversations that drive outcomes for patients, companies and the broader healthcare system.